Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizo… (NCT05469815) | Clinical Trial Compass
WithdrawnNot Applicable
Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients
Stopped: * The tool's target population has changed.
* It proved impossible to recruit 16 individuals from the original target population, despite the initial commitment of expert centres.
0Started 2023-04-13
Plain-language summary
The Lost Children Society (LCS) is a Therapeutic TableTop Role-Playing Game specifically developed for early-onset schizophrenia patient.
It is performed online via a secure teleconsultation and videoconference platform.
Patients are connected from their home, on their personal computer or tablet, equipped with headsets with microphone.
This study aims to validate the feasibility of this online Therapeutic TableTop Role Playing Game.
Who can participate
Age range
15 Years – 20 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of early onset schizophrenia
* Patient who has the capacity to understand the protocol and to perform evaluations
* Written informed consent to participate in the study given by the patient or by the parental authority of the minor patient.
* Patient with social security coverage
Exclusion Criteria:
* Intelligence quotient\<70 on Wechsler Adults Intelligence Scale-IV (for 17+ years) or the Wechsler Intelligence Scale for Children V (for 15-16 years).
* Personal history of head trauma, neurological disorder, genetic disease.
* Co-morbidities: major depressive episode or post-traumatic stress disorder unresolved or resolved within the last 6 months.
* Lack of mastery or access to a computer or personal tablet in autonomy
* Therapeutic history of metacognitive training.
* Patient under guardianship, curators or legal protection
* Patient going through a period of exacerbation of positive or negative psychotic signs likely to lead to a full-time hospitalization in a specialized environment within the next 3 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.